BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30849593)

  • 1. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity.
    Jozefíková F; Perontsis S; Koňáriková K; Švorc Ľ; Mazúr M; Psomas G; Moncol J
    J Inorg Biochem; 2022 Mar; 228():111696. PubMed ID: 35030390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant capacity and DNA-interaction studies of zinc complexes with a non-steroidal anti-inflammatory drug, mefenamic acid.
    Tarushi A; Karaflou Z; Kljun J; Turel I; Psomas G; Papadopoulos AN; Kessissoglou DP
    J Inorg Biochem; 2013 Nov; 128():85-96. PubMed ID: 23948577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: structure and biological perspectives.
    Zampakou M; Rizeq N; Tangoulis V; Papadopoulos AN; Perdih F; Turel I; Psomas G
    Inorg Chem; 2014 Feb; 53(4):2040-52. PubMed ID: 24467343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2'-dipyridyl.
    Kellett A; Howe O; O'Connor M; McCann M; Creaven BS; McClean S; Foltyn-Arfa Kia A; Casey A; Devereux M
    Free Radic Biol Med; 2012 Aug; 53(3):564-76. PubMed ID: 22659117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes.
    Li GY; Du KJ; Wang JQ; Liang JW; Kou JF; Hou XJ; Ji LN; Chao H
    J Inorg Biochem; 2013 Feb; 119():43-53. PubMed ID: 23186647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(II) interacting with the non-steroidal antiinflammatory drug flufenamic acid: structure, antioxidant activity and binding to DNA and albumins.
    Tolia C; Papadopoulos AN; Raptopoulou CP; Psycharis V; Garino C; Salassa L; Psomas G
    J Inorg Biochem; 2013 Jun; 123():53-65. PubMed ID: 23528572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESR evidence for the generation of reactive oxygen species from the copper-mediated oxidation of the benzene metabolite, hydroquinone: role in DNA damage.
    Li Y; Kuppusamy P; Zweier JL; Trush MA
    Chem Biol Interact; 1995 Feb; 94(2):101-20. PubMed ID: 7828218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.
    Ramakrishnan S; Rajendiran V; Palaniandavar M; Periasamy VS; Srinag BS; Krishnamurthy H; Akbarsha MA
    Inorg Chem; 2009 Feb; 48(4):1309-22. PubMed ID: 19140687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
    Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
    J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological evaluation of non-steroidal anti-inflammatory drugs-cobalt(II) complexes.
    Dimiza F; Papadopoulos AN; Tangoulis V; Psycharis V; Raptopoulou CP; Kessissoglou DP; Psomas G
    Dalton Trans; 2010 May; 39(19):4517-28. PubMed ID: 20372735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.
    Li L; Du K; Wang Y; Jia H; Hou X; Chao H; Ji L
    Dalton Trans; 2013 Aug; 42(32):11576-88. PubMed ID: 23843095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and crystal structures of tetracopper(II) complexes bridged by asymmetric N,N'-bis(substituted)oxamides: Molecular docking, DNA-binding and in vitro anticancer activity.
    Li XJ; Zheng K; Wang LD; Li YT; Wu ZY; Yan CW
    J Inorg Biochem; 2013 Nov; 128():97-107. PubMed ID: 23948578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
    O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
    J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
    Li Y; Kuppusamy P; Zweir JL; Trush MA
    Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and solution speciation studies on selected [Cu(NN)(OO)] complexes and an investigation of their biomimetic activity, ROS generation and their cytotoxicity in normoxic, hypoxic and anoxic environments in MCF-7 breast cancer-derived cells.
    Jenkins H; MacLean L; McClean S; Cooke G; Devereux M; Howe O; Pereira MD; May NV; Enyedy ÉA; Creaven BS
    J Inorg Biochem; 2023 Dec; 249():112383. PubMed ID: 37804698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
    Dokorou V; Primikiri A; Kovala-Demertzi D
    J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA interaction of [Cu(dmp)(phen-dion)] (dmp=4,7 and 2,9 dimethyl phenanthroline, phen-dion=1,10-phenanthroline-5,6-dion) complexes and DNA-based electrochemical biosensor using chitosan-carbon nanotubes composite film.
    Kashanian S; Khodaei MM; Roshanfekr H; Peyman H
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():642-9. PubMed ID: 23811151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.